Advertisement

Topics

Companies Related to "S0355 Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver Dysfunction" [Most Relevant Company Matches] RSS

01:29 EST 21st February 2019 | BioPortfolio

Here are the most relevant search results for "S0355 Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver Dysfunction" found in our extensive corporate database of over 50,000 company records.

Showing "S0355 Ixabepilone Treating Patients With Advanced Solid Tumors" Companies 1–25 of 6,200+

Relevant

Nereus Pharmaceuticals, Inc.

Nereus Pharmaceuticals pursues novel sources of chemical diversity to discover and develop new therapeutics. Using its unmatched expertise in marine microbiology to identify unique biologically active compounds, Nereus has two oncology drug candidates in clinical trials. Plinabulin (NPI-2358), a novel vascular disrupting agent, is being evaluated in patien...


Siamab Therapeutics, Inc.

Siamab Therapeutics, Inc. is a biopharmaceutical company developing novel cancer immunotherapies targeting cancer-specific carbohydrate antigens seen in multiple solid tumors. Siamab has developed a platform that enables the rapid discovery and development of therapeutic antibodies that bind with unprecedented specificity and affinity to this novel class o...

Threshold Pharmaceuticals, Inc.

Threshold is a biotechnology company focused on the discovery and development of drugs targeting Tumor Hypoxia, the low oxygen condition found in microenvironments of most solid tumors. This approach offers broad potential to treat most solid tumors. By selectively targeting tumor cells, we are building a pipeline of drugs that hold promise to be more effe...


TP Therapeutics Inc.

TP Therapeutics is a clinical-stage precision oncology company forging a new path for targeted cancer care. Founded in October 2013 by Dr. J. Jean Cui, the lead inventor of Pfizer’s oncology drugs crizotinib and lorlatinib, the company is developing a pipeline of novel drugs that aim to tackle treatment resistance and give new hope to patients who have ...

Grid Therapeutics, LLC

Grid Therapeutics is a biotech company based on the innovative platform for discovering and isolating human derived antibodies. Dr Edward F. Patz, Jr, is the co-founder and CEO of Grid, located in Durham, North Carolina. The lead antibody was discovered in exceptional outcome early stage lung cancer patients who did not progress to develop metastasis. ...

OncoMed Pharmaceuticals Inc.

OncoMed Pharmaceuticals is pioneering the development of novel therapeutics that target a new class of solid tumor cells, known as "cancer stem cells". The company's technology is based on a recent discovery by its co-founders that cancer stem cells are uniquely responsible for the growth and proliferation of tumors. We are leveraging our advanced understanding of cancer stem cells to identify the...

Propanc Biopharma, Inc.

Propanc Biopharma, Inc. (the "Company") is a biopharmaceutical company developing new cancer treatments initially for patients suffering from pancreatic, ovarian and colorectal cancers. The Company has developed a formulation of anti-cancer compounds, which exert a number of effects designed to control or prevent tumors from recurring and spreading through...

Turning Point Therapeutics, Inc.

Turning Point Therapeutics is a clinical-stage precision oncology company forging a new path for targeted cancer care. Founded in October 2013 by Dr. J. Jean Cui, the lead inventor of Pfizer’s oncology drugs crizotinib and lorlatinib, the company is developing a pipeline of novel drugs that aim to tackle treatment resistance and give new hope to patie...

Techniclone International Corporation

TECHNICLONE CORPORATION is engaged in the research and development of unique therapeutics for the treatment of cancer: The company utilizes innovative targeting technologies to develop products capable of destroying cancerous tumors throughout the body. The Company's Tumor Necrosis Therapy (TNT) is designed to deliver high doses of radiation directly to the core of the tumor while causing minimal ...

Turnstone Biologics

Turnstone Biologics is a clinical-stage, immuno-oncology company focused on the development of next-generation oncolytic viral immunotherapies for patients with a broad range of solid tumors. Turnstone’s unique, first-in-class oncolytic viral immunotherapies combine the potent tumor-killing effects of an oncolytic virus with a tumor-targeted T-cell va...

WILEX AG

WILEX is a biopharmaceutical company developing novel cancer therapies for the treatment of various tumors including renal and breast cancer. Therapies are based upon biologic targets directly connected to cancer progression and pathogenesis in order to provide effective and well-tolerated treatment and enhance patients' quality of life.The company has a portfolio of cancer drug candidates ranging...

Intensity Therapeutics, Inc.

Intensity Therapeutics, Inc. is a specialty pharmaceutical company whose mission is to greatly extend the lives of patients with solid tumor cancers. Intensity Therapeutics is pioneering a new approach to treat cancer referred to as in situ chemovaccination. The Company creates novel, proprietary formulations of proven chemotherapy drugs. These products, w...

CDH Proton Center

CDH Proton Center, A ProCure Center, Warrenville, Ill., is one of a handful of facilities in the country that offer proton therapy, an advanced form of radiation to treat cancer. The four-room, 60,000 sq. ft. Center, opened Oct. 19, 2010, is the first for Illinois and has the capacity to treat up to 1,500 patients a year. The precision of proton therapy sp...

Mountain Blue Cancer Care Center

Founded by Medical Director Dr. Samir Witta, Mountain Blue Cancer Care Center is a private oncology practice that delivers personalized cancer treatment through advanced genomic testing. With doctorates in both Genetics and Medicine, Dr. Witta is one of the region’s leading pioneers in developing tumor-specific treatments based on genomic testing, whi...

Jennerex Biotherapeutics, Inc.

Jennerex Biotherapeutics, Inc. is a clinical-stage biotechnology company focused on the development and commercialization of groundbreaking oncolytic immunotherapies for patients with life-threatening cancers. The company’s lead product candidate, Pexa-Vec (JX-594), is in mid-stage clinical development for the treatment of advanced primary liver cancer, ...

Iterion Therapeutics

Iterion Therapeutics is a venture-backed, clinical stage biotechnology company developing novel targeted cancer therapeutics. The company’s lead product, Tegavivint, is a potent and selective inhibitor of the Wnt/b-catenin signaling pathway, implicated in cell proliferation, differentiation, immune evasion and stem cell renewal. Tegavivint demonstrate...

North American Scientific

Our Mission To pursue with passion the development and introduction of innovative new products that empower physicians and patients with individualized, life-saving treatment solutions. Company Overview Little more than ten years ago, radiation oncology was as much a source of frustration as of hope for its dedicated professionals. Physicians had to face the fact that they often did more harm...

Arch Oncology, Inc.

Arch Oncology, Inc. is a privately-held, clinical-stage immuno-oncology company focused on the discovery and development of best-in-class antibody therapies for the treatment of patients with cancer. The Company’s next-generation anti-CD47 antibodies are highly differentiated, with the potential to improve upon the safety and efficacy profile relative...

Arkansas Heart Hospital

Arkansas Heart Hospital is dedicated to the diagnosis and treatment of heart disease. By specializing in the nation's number one killer, patients at Arkansas Heart Hospital experience the benefits of advanced technology while receiving services that focus on their individual needs. The concept of a facility dedicated to diagnosing and treating patients with cardiovascular disease allows staff and ...

Endocare

Endocare's mission is to radically improve patients lives through ground breaking core technology. Endocare promotes its cryotherapy technology to urologists for the treatment of prostate cancer and renal tumors, however, we are expanding our focus across a number of surgical markets, including the ablation of tumors in the lung and liver, as well as pain management.

KE Eye Centers of Texas

KE Eye Centers of Texas is a leading surgical and medical eye care provider based in the Dallas-Fort Worth Metroplex. Since 1983, KE Eye Centers of Texas has been building an Ophthalmology Center of Excellence, powered by an expert team of board certified physician specialists, the most advanced laser technology and a culture of quality and extraordinary p...

MagForce AG

MagForce AG, listed in the entry standard (MF6), together with its subsidiary MAGFORCE USA, Inc. is a leading medical device company in the field of nanomedicine in oncology. The Group's proprietary NanoTherm(R) therapy enables the targeted treatment of solid tumors through the intratumoral generation of heat via activation of superparamagnetic nanoparticl...

Direct Therapeutics, Inc.

Direct Therapeutics, Inc. is a development-stage pharmaceutical company using its patented Solvent-Facilitated Perfusion technology to create new drugs for the localized and regional treatment of solid-tumor cancers. Our products are designed for direct injection to target tissue with minimal invasion of healthy tissue. They contain active ingredients in organic solvent vehicles that facilitate th...

Solid Dosage Training, Inc.

Solid Dosage Training is a California Corporation offering both introductory and single subject seminars on 26 different solid dosage manufacturing topics. We also lecture with the Center for Professional Advancement’s Institute of Applied Pharmaceutical Science. We travel the world training operators, staff and management is solid dosage and hard shell encapsulation.Mr. Rowley is grateful to Wa...

SOLID Datasystems, Inc.

SOLID Datasystems, Inc. pharmacy information systems are used by a wide range of pharmacies to fill millions of prescriptions per year. Explore our site to find out how SOLID/Rx and SOLID/POS can benefit your pharmacy.


More From BioPortfolio on "S0355 Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver Dysfunction"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks